As your investment adviser I am pleased to report that my brain is in good working order. I know this because, you see, I volunteered for that brain scan.
You'll know Tom Bulford by now – he's our point man on the booming biotech industry.
Last week in Penny Sleuth I wrote about a big new breakthrough in biotechnology called CRISPR. CRISPR is a new technique for writing, deleting and generally mucking around with...
Two years ago, I didn't know anything about biotech. And I didn't care either.